Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer for which no early diagnostic method is available. The immune surveillance hypothesis suggests that the immune system plays crucial roles in tumor development and progression. We validated a PDAC-specific biomarker derived from peripher...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2022-02, Vol.14 (3), p.853
Hauptverfasser:	Jang, Sung-Ill, Cho, Jae-Hee, Kim, So-Young, Hong, In-Young, Park, Joon-Seong, Lee, Hye-Sun, Park, Goeun, Kim, Jong-Kyoung, Lee, Hyung-Keun, Lee, Dong-Ki
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Antigens Bile ducts Biomarkers Blood Cysts Diagnosis Disease Gene expression Immune system Immunosurveillance Laboratories Leukocytes (mononuclear) Medical prognosis mRNA Pancreas Pancreatic cancer Pancreatic diseases Pancreatitis Patients Peripheral blood mononuclear cells Statistical analysis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!